Navigation Links
Insight into mechanisms of diabetes-induced microvascular disease reveals new therapies
Date:7/16/2008

New findings from Bristol scientists could lead to future treatments to prevent lower limb amputations in diabetes - which currently affect 100 people a week in the UK (source Diabetes UK).

The research from the University of Bristol is published online in Circulation Research and was funded by the British Heart Foundation (BHF) and the European Vascular Genomic Network of Excellence (EVGN).

Diabetes can have serious complications like gangrene and skin ulcers due to a restriction of blood supply to and healing capacity of the affected areas and this causes the dysfunction of cells lining the blood vessels. Legs and feet are often severely affected, and, after blood supply is obstructed or injury, the tissue seems to be unable to heal itself by growing new blood vessels making the situation much worse. If gangrenous wounds fail to heal amputation may be the only option.

Dr Costanza Emanueli, BHF Reader at Bristol University and colleagues at the Bristol Heart Institute have previously found that a group of growth factors - known as neurotrophins - play a role in the vascular system. Growth factors act on two completely different types of cellular receptors. One type, trk, mediates positive actions, such as survival and growing new blood vessels and the other, p75NTR, has not been comprehensively characterised.

In healthy blood vessels, the cells that line the blood vessels do not possess the p75NTR receptor, and the development of new blood vessels and healing of the obstructed blood supply and wounds is rapid. However, diabetes causes the cells lining the blood vessels to produce the p75NTR receptor, and prevents the growth of new blood vessels necessary for blood supply and healing of damaged tissue.

Dr Emanueli's group found that if they put the receptor gene into healthy blood vessel cells, the cells became dysfunctional. Equally, injecting the gene into healthy muscle and then restricting blood su
'/>"/>

Contact: joanne.fryer@bristol.ac.uk
joanne.fryer@bristol.ac.uk
44-117-331-7276
University of Bristol
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Pitt-led research provides insight into development of congenital circulatory defects
2. MedInsights, Inc. Selects Douglas Young as VP - Sales & Product Development
3. Bacterial peptide provides new insight into common tumor suppressor
4. Circulating Tumor Cells Reveal Insights Into Lung Cancers
5. Leaders Develop Leaders: Insights from Global Benchmarking Councils 10th Annual Human Resources Conference
6. CVS Caremark to Present Insights on Redefining the Consumer Health Care Experience at AHIP Institute 2008
7. Parks Associates Analysts Present Insights on Broadband, Digital Content, Advertising, Home Systems, and Digital Health at CONNECTIONS(TM)
8. New molecular insight into amboebic dysentery
9. Molecular insight begins Trofex Phase 1 trial for detection of metastatic prostate cancer
10. New insight into RA patient priorities and motivators for clinical trial involvement
11. Molecular insight begins Trofex Ph. 1 trial for detection of metastatic prostate cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...new interactive anatomy education apps from Modali...alth sciences learning opportunities for iPhone an... (Vocus) November 27, 2009 -- Modality, Inc. and...on of Wolters Kluwer Health, today announced the a... the App Store. Clemente’s Anatomy, Rohen&rs...
(Date:11/26/2009)...er of Americans living with diabetes will nearly d...1 million in 2034. Over the same period, spending ...illion to $336 billion, even with no increase in t... University of Chicago report in the December issu... diabetes covered by Medicare will rise from 8.2 m...
(Date:11/26/2009)... an emotional rollercoaster, study finds , ... the fear factor meets the jubilant sports fan. ,...lly those who root for the winning team -- enjoy t...ed match and victory was in doubt, producing feeli...his Thanksgiving weekend as you,re glued to the TV...
(Date:11/26/2009)...ch Triangle Dental (RTDental), a leading dental gr...unced the expansion of its services to include LUM...acmillan. , Durham, NC... announce that Dr. Doug Macmillan, an experienced ...nal advanced training seminar. RTDental’s a...
(Date:11/25/2009)...5 When most people hear...t a chiropractor can also give patients the help t...oint, which is where your jaw (mandible) contacts/...he most common symptoms associated with TMJ dysfun...f the jaw. But many other symptoms can be caused ...
Breaking Medicine News(10 mins):Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2
...rding to Millennium Research Group,s (MRG,s) new ... US spinal nonfusion technology segment will see a...ly at the expense of traditional spinal fusion. N...of new spinal nonfusion products will result in an...
... Integrated,s Synergy Targeted Population Manageme...roving health for Medicaid subscribers , , PORTLA...non-profit health plan that provides Medicaid and ...rove the health and quality of life for CareOregon...
...e Quantum Group, Inc. (NYSE Amex: QGP ) ( www.Qu...llocation of people and resources from other Compa...POWER) platform. As Quantum continues to set the ...WeR (Personal Wellness electronic Record) is the...
...RYE, N.Y., March 25 Curemark, LLC, a drug researc... of neurological diseases, announced today that th...red the company,s Investigational New Drug (IND) a... trials at multiple sites across the US in the sec...
...re Group at Frost & Sullivan is pleased to a...tation on the European Medical Imaging Equipment M...4 p.m. GMT. , , (Logo: http://www.newscom.com/cg... of electro-medical equipment have a formal risk m...
... Cord Blood America, Inc. (OTC Bulletin Board: CB...on company ( http://www.cordblood-america.com ) fo...m cells to families nationwide and internationally...e number of authorized (not outstanding) common sh...
Other Medicine News:Health News:US Spinal Nonfusion Procedures Set to Increase Nearly Five Times From 2008 to 2013, According to Millennium Research Group 2Health News:CareOregon and Health Integrated Partner to Enhance Services for Oregonians with Chronic Illness 2Health News:CareOregon and Health Integrated Partner to Enhance Services for Oregonians with Chronic Illness 3Health News:The Quantum Group Announces Resource Reallocation to Advance PWeR(TM) Platform 2Health News:The Quantum Group Announces Resource Reallocation to Advance PWeR(TM) Platform 3Health News:The Quantum Group Announces Resource Reallocation to Advance PWeR(TM) Platform 4Health News:The Quantum Group Announces Resource Reallocation to Advance PWeR(TM) Platform 5Health News:Curemark Receives Investigational New Drug Clearance for CM-AT for Autism 2Health News:Curemark Receives Investigational New Drug Clearance for CM-AT for Autism 3Health News:Leveraging the Third Amendment Ruling the Risk Management Process: Frost & Sullivan's Assessment of Regulations for Medical Imaging Equipment in Europe 2Health News:Leveraging the Third Amendment Ruling the Risk Management Process: Frost & Sullivan's Assessment of Regulations for Medical Imaging Equipment in Europe 3
(Date:11/25/2009)...Nov. 25 ChemoCentryx, Inc., anno...he Company,s PROTECT-1 (the Prospective Randomized... of Traficet-EN(TM) (CCX282-B) in patients with mo...ical efficacy with a favorable safety and tolerabi...clinical efficacy in the reduction of disease seve...
(Date:11/24/2009)...PRNewswire/ -- ,, WHAT: Rom Houbens, a Belgia...llowing an auto accident, was actually fully consc...t of a Good Morning America segment. The DynaVox ...ow people with Locked-in Syndrome and other condit...orning America -- Tuesday, November 24 available...
(Date:11/24/2009)... 24 Quest Diagnostics In...vider of diagnostic testing, information and servi...e 21st Annual Piper Jaffray Healthcare Conference ...or Wednesday, December 2, 2009 at 9:30 a.m. Easter...ill reaffirm its 2009 guidance for revenue growth ...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Perspectives Ltd and Chicagoland Chamber of Commerce Partner to Promote Drug Free Workplaces EAP Provider Offers Workshops to Help Businesses Underst 59794 1Perspectives Ltd and Chicagoland Chamber of Commerce Partner to Promote Drug Free Workplaces EAP Provider Offers Workshops to Help Businesses Underst 59794 2Perspectives Ltd and Chicagoland Chamber of Commerce Partner to Promote Drug Free Workplaces EAP Provider Offers Workshops to Help Businesses Underst 59794 3Johnson Matthey Expands San Diego Facility 59790 1Johnson Matthey Expands San Diego Facility 59790 2Philips Launches DirectLife a New Personal Fitness Program to Help People Lead Healthier Lives 59786 1Philips Launches DirectLife a New Personal Fitness Program to Help People Lead Healthier Lives 59786 2Philips Launches DirectLife a New Personal Fitness Program to Help People Lead Healthier Lives 59786 3Philips Launches DirectLife a New Personal Fitness Program to Help People Lead Healthier Lives 59786 4
...Med today reported one year,survival results from ...imexon(R) (imexon for injection) in combination wi... III or stage IV metastatic malignant,melanoma. Re... Phase I and,Phase II shows a 11.7 month overall m...onth overall mean survival in the subset of patien...
...traZeneca (NYSE:,AZN) today announced that the com...rug Applications (sNDAs) to the U.S. Food and Drug...M) (quetiapine fumarate),Extended-Release Tablets ...es associated with bipolar disorder and the treatm... disorder., The bipolar mania submission is based...
Other Medicine Technology:AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma 2AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma 3AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma 4AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression 2AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression 3AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression 4AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression 5AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression 6AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression 7
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
Medicine Products: